Literature DB >> 19470858

An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.

Benjamin Chavez1, Michael A Sopko, Megan J Ehret, Raphael E Paulino, Kyle R Goldberg, Kristine Angstadt, Gregory T Bogart.   

Abstract

OBJECTIVE: To review recent literature on the different stimulant preparations regarding efficacy and safety in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) and describe advantages and disadvantages of the many available dosage formulations. DATA SOURCES: Literature retrieval was performed through PubMed/MEDLINE (2005-December 2008) using the terms methylphenidate, amphetamines, central nervous system stimulants, and attention-deficit/hyperactivity disorder. In addition, reference citations from publications identified were reviewed and drug manufacturers were contacted for any possible additional references. STUDY SELECTION AND DATA EXTRACTION: Double-blind clinical trials found using the search criteria listed above were included for review. Open-label studies and studies prior to 2005 were included if no double-blind trials were published for that formulation within the time period reviewed. DATA SYNTHESIS: The literature reviewed here demonstrates the efficacy and safety of stimulant medications in children and adolescents with ADHD. However, there are 19 different formulations of stimulants, leading to confusion and errors in prescribing and dispensing of these drugs. Knowing and understanding the advantages and disadvantages of the different formulations can lead to individualized treatment. Formulations like Concerta, Focalin-XR, Adderall-XR, and Vyvanse provide the convenience of once-daily dosing. Each of these provides varying amount of stimulants at different times of the day. Vyvanse has a unique delivery system that may lower the risk of patients abusing their medication. Daytrana gives patients more control over their dosing by being able to choose when the patch is removed; it is also a feasible alternative for children who cannot swallow pills. For patients who cannot swallow tablets or capsules, the capsules of Focalin-XR, Adderall-XR, Metadate-CD, and Ritalin-LA can be opened and sprinkled on applesauce.
CONCLUSIONS: Stimulants are effective medications to treat the symptoms of ADHD. The multiple available dosage forms allow for individualization of treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19470858     DOI: 10.1345/aph.1L523

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  18 in total

Review 1.  Assessing the roles of stimulants/stimulant-like drugs and dopamine-agonists in the treatment of bipolar depression.

Authors:  Bernardo Dell'Osso; Terence A Ketter; Laura Cremaschi; Gregorio Spagnolin; A Carlo Altamura
Journal:  Curr Psychiatry Rep       Date:  2013-08       Impact factor: 5.285

Review 2.  Rational use of generic psychotropic drugs.

Authors:  Maren Carbon; Christoph U Correll
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

Review 3.  Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge.

Authors:  Yu-Shu Huang; Ming-Horng Tsai
Journal:  CNS Drugs       Date:  2011-07       Impact factor: 5.749

4.  ADHD stimulants and their effect on height in children.

Authors:  Ran D Goldman
Journal:  Can Fam Physician       Date:  2010-02       Impact factor: 3.275

5.  D-Amphetamine Exposure Differentially Disrupts Signaling Across Ontogeny in the Zebrafish.

Authors:  Bradley J Serpa; Jennifer D Bullard; Victoria C Mendiola; Crystal J Smith; Brandon Stewart; Lisa R Ganser
Journal:  Bioelectricity       Date:  2019-06-14

Review 6.  Dexmethylphenidate extended release: a review of its use in the treatment of attention-deficit hyperactivity disorder.

Authors:  Marit D Moen; Susan J Keam
Journal:  CNS Drugs       Date:  2009-12       Impact factor: 5.749

7.  Do college students improve their grades by using prescription stimulants nonmedically?

Authors:  Amelia M Arria; Kimberly M Caldeira; Kathryn B Vincent; Kevin E O'Grady; M Dolores Cimini; Irene M Geisner; Nicole Fossos-Wong; Jason R Kilmer; Mary E Larimer
Journal:  Addict Behav       Date:  2016-07-19       Impact factor: 3.913

Review 8.  Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors.

Authors:  Sharon M Castellino; Nicole J Ullrich; Megan J Whelen; Beverly J Lange
Journal:  J Natl Cancer Inst       Date:  2014-07-30       Impact factor: 13.506

9.  Pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: clinical strategies.

Authors:  Anna C Shier; Thomas Reichenbacher; Harinder S Ghuman; Jaswinder K Ghuman
Journal:  J Cent Nerv Syst Dis       Date:  2012-12-20

10.  DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics.

Authors:  Darko Turic; James Swanson; Edmund Sonuga-Barke
Journal:  Pharmgenomics Pers Med       Date:  2010-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.